Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
तुलना करने के लिए मीट्रिक्स | BAVA | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBAVAपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 12.0x | −1.2x | −0.5x | |
PEG अनुपात | −0.35 | −0.50 | 0.00 | |
क़ीमत/बुक | 1.0x | 1.1x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.1x | 3.3x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 106.6% | 58.9% | |
उचित मूल्य अपसाइड | अनलॉक करें | 10.3% | 8.0% | अनलॉक करें |